BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21612925)

  • 1. 3-substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities.
    Rao VK; Chhikara BS; Shirazi AN; Tiwari R; Parang K; Kumar A
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3511-4. PubMed ID: 21612925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot regioselective synthesis of tetrahydroindazolones and evaluation of their antiproliferative and Src kinase inhibitory activities.
    Rao VK; Chhikara BS; Tiwari R; Shirazi AN; Parang K; Kumar A
    Bioorg Med Chem Lett; 2012 Jan; 22(1):410-4. PubMed ID: 22119472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities.
    Kumar A; Ahmad I; Chhikara BS; Tiwari R; Mandal D; Parang K
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1342-6. PubMed ID: 21300544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. InCl3 mediated one-pot multicomponent synthesis, anti-microbial, antioxidant and anticancer evaluation of 3-pyranyl indole derivatives.
    Lakshmi NV; Thirumurugan P; Noorulla KM; Perumal PT
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5054-61. PubMed ID: 20675130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Src kinase inhibitory and anticancer activities of 1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols.
    Sharma D; Sharma RK; Bhatia S; Tiwari R; Mandal D; Lehmann J; Parang K; Olsen CE; Parmar VS; Prasad AK
    Biochimie; 2010 Sep; 92(9):1164-72. PubMed ID: 20447438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and anticancer activity of 3-[(3'-methyl-4'-(substituted phenyl)-1',3'-butadienyl] indole derivatives].
    Xu L; Liu J; Xu SP
    Yao Xue Xue Bao; 2001 Jan; 36(1):29-33. PubMed ID: 12579856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, inhibition of NO production and antiproliferative activities of some indole derivatives.
    Sinicropi MS; Caruso A; Conforti F; Marrelli M; El Kashef H; Lancelot JC; Rault S; Statti GA; Menichini F
    J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1148-53. PubMed ID: 19555184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
    Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A
    Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities].
    Dong XC; Zhou FS; Zheng JB; Wen R
    Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of Indolin-2-one derivatives bearing the 4-thiazolidinone moiety.
    Wang S; Zhao Y; Zhu W; Liu Y; Guo K; Gong P
    Arch Pharm (Weinheim); 2012 Jan; 345(1):73-80. PubMed ID: 21932254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
    Kiliç Z; Isgör YG; Olgen S
    Arch Pharm (Weinheim); 2009 Jun; 342(6):333-43. PubMed ID: 19475593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer activity of new (tetrazol-5-yl)methylindole derivatives and their acyclic c-nucleoside analogs.
    El-Sayed WA; El-Kosy SM; Ali OM; Emselm HM; Abdel-Rahman AA
    Acta Pol Pharm; 2012; 69(4):669-77. PubMed ID: 22876609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling.
    Bouchikhi F; Anizon F; Moreau P
    Eur J Med Chem; 2009 Jun; 44(6):2705-10. PubMed ID: 19232788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.
    Verones V; Flouquet N; Farce A; Carato P; Leonce S; Pfeiffer B; Berthelot P; Lebegue N
    Eur J Med Chem; 2010 Dec; 45(12):5678-84. PubMed ID: 20884092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.
    Cao X; You QD; Li ZY; Liu XR; Xu D; Guo QL; Shang J; Chern JW; Chen ML
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6206-9. PubMed ID: 18930653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile.
    Chiang CC; Lin YH; Lin SF; Lai CL; Liu C; Wei WY; Yang SC; Wang RW; Teng LW; Chuang SH; Chang JM; Yuan TT; Lee YS; Chen P; Chi WK; Yang JY; Huang HJ; Liao CB; Huang JJ
    J Med Chem; 2010 Aug; 53(16):5929-41. PubMed ID: 20681538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative activities of isoindigo and azaisoindigo derivatives.
    Bouchikhi F; Anizon F; Moreau P
    Eur J Med Chem; 2008 Apr; 43(4):755-62. PubMed ID: 17628214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
    J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.